Target intelligence / Profile preview

Collagen (extracellular matrix, adipose tissue) (null)

Target
null
Molecular classification
Structural protein, Extracellular matrix component
01

Overview

Collagens are the most abundant structural proteins in the extracellular matrix of adipose tissue, essential for maintaining tissue architecture, supporting adipocyte function, and regulating mechanical stability and signaling[1][3]. Multiple collagen types (notably type I, III, IV, and VI) coexist, forming both the basement membrane and interstitial matrix[1][3][5]. Collagen remodeling is crucial for healthy adipose tissue expansion, and dysregulation can lead to fibrosis, inflammation, insulin resistance, and metabolic disease[5]. Although collagens are not classical drug targets, pathways controlling collagen deposition, crosslinking, or degradation are therapeutic interests, particularly in obesity, metabolic syndrome, and fibrotic diseases[5].

Other names
Collagen fibersECM collagenadipose tissue collagentype I collagen (major subtype)type III collagentype VI collagen
02

Mechanism of action

MMPs cleave collagen to allow adipose expansion or remodeling. Some research considers targeting collagen crosslinking, deposition, or degradation to modulate adipose tissue health.

03

Biological functions

Tissue architecture and structural supportRegulation of adipocyte size and differentiationMechanical stability and elasticityModulation of cell behavior, migration, proliferationReservoir for growth factors and cytokines
04

Disease associations

Obesity (altered ECM/collagen remodeling contributes to adipose fibrosis)Insulin resistance/type 2 diabetes (fibrosis impairs healthy adipose expansion)Cancer (modulation of tumor microenvironment)Fibrotic and degenerative diseases (e.g., atherosclerosis, arthritis)Inflammation (macrophage infiltration and cytokine regulation)
05

Safety considerations

Non-selective modulation of collagen may impair normal tissue integrity, wound healing, or lead to unwanted fibrosis or instability
06

Interacting drugs

Indirectly, matrix metalloproteinase (MMP) inhibitors or activators

1 more in the full profile.

07

Biomarkers

Collagen fragments (e.g., circulating collagen VI or I peptides)ECM remodeling products (used in research as markers for adipose fibrosis or dysfunction)

Beyond the preview

Go deeper on Collagen (extracellular matrix, adipose tissue) (null).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Collagen (extracellular matrix, adipose tissue) (null).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call